ISSN: 1746-0751

Journal Home

Journal Guideline

Regenerative Medicine Q2 Unclaimed

Future Medicine Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Regenerative Medicine is a journal indexed in SJR in Biomedical Engineering and Embryology with an H index of 72. It has an SJR impact factor of 0,471 and it has a best quartile of Q2. It has an SJR impact factor of 0,471.

Regenerative Medicine focuses its scope in these topics and keywords: human, cells, stem, published, pluripotent, pulp, reach, research, stromal, studies, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Embryology (Q2) Biomedical Engineering (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,471

SJR Impact factor

72

H Index

81

Total Docs (Last Year)

274

Total Docs (3 years)

4251

Total Refs

644

Total Cites (3 years)

256

Citable Docs (3 years)

2.15

Cites/Doc (2 years)

52.48

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Advanced Biosystems Q2
Annals of Biomedical Engineering Q2
Cell Transplantation Q2
Frontiers in Neurorobotics Q2
Tissue Engineering - Part A Q2

Compare this journals

Aims and Scope

Best articles by citations

Hypocellularity and absence of compaction as criteria for embryonic death

Tendon and ligament engineering: from cell biology toin vivoapplication

Update on therapeutic vascularization strategies

3D scaffolds for bone marrow stem cell support in bone repair

Applications of gene therapy and adult stem cells in bone bioengineering

Engineering stem cells for therapy

Bone marrow-derived stem cells in neurological diseases: stones or masons?

What is the role of the vasculature in the neural stem cell niche?

Research Highlights

Controlled mechanotransduction in therapeutic MSCs: can remotely controlled magnetic nanoparticles regenerate bones?

Definitive endoderm from embryonic stem cells

California dreaming? A new start for regenerative medicine in the Golden State

SHOW MORE ARTICLES

Conversion of embryonic stem cells into pancreatic beta-cell surrogates guided by ontogeny

Engineered mesenchymal stem cells for cartilage repair

Reimbursement and adoption of advanced therapies: the 5-C framework

The time has come to engineer tissues and not just tissue engineer

Reversal of Type 1 diabetes mellitus without exogenous cells

Does the regeneration of hippocampal neurons offer hope for the treatment of cognitive deficits?

Delivery of mesenchymal stem cells in biomimetic engineered scaffolds promotes healing of diabetic ulcers

Letter to the editor: Therapeutic misconception and the role of the Research Ethics Committee

Portrayal of umbilical cord blood research in the North American popular press: promise or hype?

The past, present and future of ligament regenerative engineering

It's endoderm...definitively!

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions from May 1, 2014 until June 30, 2014